The role of antithrombotic therapy on the patency of peripheral bypasses

被引:5
作者
Bucek, RA
Schnürer, G
Ahmadi, A
Polterauer, P
Kretschmer, G
Minar, E
机构
[1] Univ Vienna, Gen Hosp Vienna, Dept Angiol, A-1090 Vienna, Austria
[2] Univ Vienna, Gen Hosp Vienna, Dept Vasc Surg, A-1090 Vienna, Austria
[3] Univ Vienna, Ludwig Boltzmann Inst Interdisziplinare, Klin Gefassmed Forsch, A-1090 Vienna, Austria
来源
VASA-JOURNAL OF VASCULAR DISEASES | 2000年 / 29卷 / 03期
关键词
anticoagulation; antiplatelet drugs; vascular surgery; peripheral arterial occlusive disease; peripheral bypasses;
D O I
10.1024/0301-1526.29.3.163
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
peripheral bypass surgery is a well-established treatment for symptomatic atherosclerotic disease of the legs. To improve the long-term patency antithrombotic drugs and other adjuvant treatment are applied In this review we summarize the results of randomized studies concerning antithrombotic treatment for prophylaxis after peripheral bypass surgery Heparin is used routinely intra- and perioperatively without strong data, and according to few data low molecular weight heparin may be superior in this situation. Aspirin had positive effects in placebo-controlled studies after infrainguinal PTFE-bypasses, furthermore it is recommended due to its general cardiovascular risk reduction. Ticlopidine improved long-term patency in one randomized study after venous bypass surgery. Otherwise there are some data that long-term oral anticoagulation may be preferable in patients after venous bypass surgery.
引用
收藏
页码:163 / 167
页数:5
相关论文
共 42 条
[41]  
WATSON HR, 1999, BRIT J SURG, P981
[42]  
Wittwer T, 1998, MED WELT, V49, P67